124010-13-5

Basic information

• Product Name: 1-(bromomethyl)-4-chloro-2,5-dimethoxybenzene
• Synonyms: 1-(bromomethyl)-4-chloro-2,5-dimethoxybenzene
• CAS NO: 124010-13-5
• Molecular Weight: 265.534
• Mol File: 124010-13-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1-(bromomethyl)-4-chloro-2,5-dimethoxybenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(bromomethyl)-4-chloro-2,5-dimethoxybenzene(124010-13-5)
• EPA Substance Registry System: 1-(bromomethyl)-4-chloro-2,5-dimethoxybenzene(124010-13-5)

Safety Data

• Hazardous Substances Data: 124010-13-5(Hazardous Substances Data)

Upstream product

• 90064-48-5 4-chloro-2,5-dimethoxybenzaldehyde 
• 2100-42-7 2-chloro-1,4-dimethoxybenzene 
• 1394837-77-4 (4-chloro-2,5-dimethoxyphenyl)methanol 
• 128-08-5 N-Bromosuccinimide 
• 2675-78-7 2-Chloro-5-methyl-1,4-dimethoxybenzene 
• 24599-58-4 2,5-dimethoxy toluene 
• 95-71-6 2-methylbenzene-1,4-diol 

Downstream Products

• 1394837-86-5 (Z)-5-(2-chloro-4-(4-chloro-2,5-dimethoxyphenyl)but-2-enyl)benzene-1,3-diol 
• 1394837-85-4 (E)-5-(2-chloro-4-(4-chloro-2,5-dimethoxyphenyl)but-2-enyl)benzene-1,3-diol 
• 1394837-87-6 (E)-5-(2-chloro-4-(4-chloro-2,5-dihydroxyphenyl)but-2-enyl)benzene-1,3-diol 
• 124010-11-3 Ethyl 4-(acetyloxy)-6-chloro-5,8-dimethoxy-2-naphthalenecarboxylate 
• 124010-10-2 3-Carbethoxy-4-(4-chloro-2,5-dimethoxyphenyl)-3-butenoic acid 
• 305347-50-6 4-(4-chloro-2,5-dimethoxyphenyl)-but-1-yne 
• 90064-48-5 4-chloro-2,5-dimethoxybenzaldehyde 

Relevant articles and documents

MLKL INHIBITORS

Purine derivatives that inhibit cellular necroptosis and/or human MLKL, pharmaceutical compositions thereof, and methods of treating an MLKL-mediated disorder with an effective amount of the compound or composition. Said MLKL-mediated disorder is pathology associated necroptosis, including ischemia-reperfusion damage, neurodegeneration, and inflammatory diseases such as acute pancreatitis, multiple sclerosis, inflammatory bowel disease, and allergic colitis.

Ethyl(or methyl) 4-acetoxy(or propionyloxy)-5,6,7 or 8-di(or tri-)substituted-2-naphthoates

Novel antiviral ring-substituted ethyl or methyl 4-acetoxy (or propionyloxy)-2-naphthoates are provided.